| Dr Mark G Bowles, MD | |
|
425 Bmh Physicians Office Bldg, Maryville, TN 37804-5807 | |
| (865) 980-5260 | |
| (865) 980-5261 |
| Full Name | Dr Mark G Bowles |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 35 Years |
| Location | 425 Bmh Physicians Office Bldg, Maryville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548260599 | NPI | - | NPPES |
| Q005391 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD0000020986 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blount Memorial Hospital | Maryville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blount Memorial Physician Group Inc | 6406844174 | 242 |
News Archive
A new study published on the preprint server bioRxiv* describes the results of genomic sequencing of the virus, which may help trace the routes of transmission of the virus from person to person, and from country to country.
Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced that Allscripts and Inovalon have entered into a multi-year agreement that enables Inovalon's advanced healthcare data analytics for payers to leverage Allscripts Electronic Health Record (EHR) Platform to improve clinical and quality outcomes and financial performance.
Oxford BioMedicaplc, a leading gene therapy company, today announces that it has signed a research collaboration agreement with ImaginAb, Inc., a biotechnology company specialising in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications, to engineer an in vivo diagnostic imaging agent using an antibody targeting the Company's proprietary 5T4 tumour antigen.
A team of scientists from the National University of Singapore (NUS) has established novel insights into the relationship between breast cancer tumour intracellular redox environment and the cancer cells' ability to become invasive.
David Williams is the first human being ever to have a new radiation treatment implanted in the center of his brain tumor.
› Verified 3 days ago
| Entity Name | Blount Memorial Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699710194 PECOS PAC ID: 6406844174 Enrollment ID: O20040503000547 |
News Archive
A new study published on the preprint server bioRxiv* describes the results of genomic sequencing of the virus, which may help trace the routes of transmission of the virus from person to person, and from country to country.
Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced that Allscripts and Inovalon have entered into a multi-year agreement that enables Inovalon's advanced healthcare data analytics for payers to leverage Allscripts Electronic Health Record (EHR) Platform to improve clinical and quality outcomes and financial performance.
Oxford BioMedicaplc, a leading gene therapy company, today announces that it has signed a research collaboration agreement with ImaginAb, Inc., a biotechnology company specialising in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications, to engineer an in vivo diagnostic imaging agent using an antibody targeting the Company's proprietary 5T4 tumour antigen.
A team of scientists from the National University of Singapore (NUS) has established novel insights into the relationship between breast cancer tumour intracellular redox environment and the cancer cells' ability to become invasive.
David Williams is the first human being ever to have a new radiation treatment implanted in the center of his brain tumor.
› Verified 3 days ago
| Entity Name | Tennessee Urology Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669416442 PECOS PAC ID: 7618952706 Enrollment ID: O20040622001531 |
News Archive
A new study published on the preprint server bioRxiv* describes the results of genomic sequencing of the virus, which may help trace the routes of transmission of the virus from person to person, and from country to country.
Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced that Allscripts and Inovalon have entered into a multi-year agreement that enables Inovalon's advanced healthcare data analytics for payers to leverage Allscripts Electronic Health Record (EHR) Platform to improve clinical and quality outcomes and financial performance.
Oxford BioMedicaplc, a leading gene therapy company, today announces that it has signed a research collaboration agreement with ImaginAb, Inc., a biotechnology company specialising in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications, to engineer an in vivo diagnostic imaging agent using an antibody targeting the Company's proprietary 5T4 tumour antigen.
A team of scientists from the National University of Singapore (NUS) has established novel insights into the relationship between breast cancer tumour intracellular redox environment and the cancer cells' ability to become invasive.
David Williams is the first human being ever to have a new radiation treatment implanted in the center of his brain tumor.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark G Bowles, MD 103 W Broadway Ave, Maryville, TN 37801-4703 Ph: (865) 273-1752 | Dr Mark G Bowles, MD 425 Bmh Physicians Office Bldg, Maryville, TN 37804-5807 Ph: (865) 980-5260 |
News Archive
A new study published on the preprint server bioRxiv* describes the results of genomic sequencing of the virus, which may help trace the routes of transmission of the virus from person to person, and from country to country.
Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced that Allscripts and Inovalon have entered into a multi-year agreement that enables Inovalon's advanced healthcare data analytics for payers to leverage Allscripts Electronic Health Record (EHR) Platform to improve clinical and quality outcomes and financial performance.
Oxford BioMedicaplc, a leading gene therapy company, today announces that it has signed a research collaboration agreement with ImaginAb, Inc., a biotechnology company specialising in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications, to engineer an in vivo diagnostic imaging agent using an antibody targeting the Company's proprietary 5T4 tumour antigen.
A team of scientists from the National University of Singapore (NUS) has established novel insights into the relationship between breast cancer tumour intracellular redox environment and the cancer cells' ability to become invasive.
David Williams is the first human being ever to have a new radiation treatment implanted in the center of his brain tumor.
› Verified 3 days ago
Dr. Rebecca S Lavelle, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 425 Bmh Physicians Office Bldg, Maryville, TN 37804 Phone: 865-980-5260 Fax: 865-980-5261 | |
Dr. Joshua Bryant Byrd, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 425 Bmh Physicians Office Bldg, Maryville, TN 37804 Phone: 865-980-5260 Fax: 865-980-5261 | |
James D Briggs, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 425 Bmh Physicians Office Bldg, Maryville, TN 37804 Phone: 865-980-5260 Fax: 865-980-5261 |